Butyrate attenuates the stemness of lung cancer cells through lysosome Fe2+- and SLC7A11-mediated ferroptosis
Cancer stem cells (CSCs) are considered key contributors to tumor progression, and ferroptosis has been identified as a potential target for CSCs. We have previously shown that butyrate enhances the ferroptosis induced by erastin in lung cancer cell, this study aimed to investigate the impact of but...
Main Authors: | Rui Bi, Lianyong Jiang, Rui Hu, Bohan Wen, Zhaolei Jiang, Hongtao Liu, Ju Mei |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-04-01
|
Series: | Heliyon |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844024041240 |
Similar Items
-
Sodium Butyrate Induces CRC Cell Ferroptosis via the CD44/SLC7A11 Pathway and Exhibits a Synergistic Therapeutic Effect with Erastin
by: Zhongbo Bian, et al.
Published: (2023-01-01) -
SLC7A11 as a Gateway of Metabolic Perturbation and Ferroptosis Vulnerability in Cancer
by: Jaewang Lee, et al.
Published: (2022-12-01) -
CEBPG suppresses ferroptosis through transcriptional control of SLC7A11 in ovarian cancer
by: Xiaoqian Zhang, et al.
Published: (2023-05-01) -
KCNA1 promotes the growth and invasion of glioblastoma cells through ferroptosis inhibition via upregulating SLC7A11
by: Weichao Wang, et al.
Published: (2024-01-01) -
AADAC protects colorectal cancer liver colonization from ferroptosis through SLC7A11-dependent inhibition of lipid peroxidation
by: Rongquan Sun, et al.
Published: (2022-09-01)